ross edmund burke jr  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address co jdj family office services po box  boston ma   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  azrxazurrx biopharma incdehealthdrugpharmaceutical preparationsross edmund burke jrmatpdi dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved insider trading  ross edmund burke jr  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  ross edmund burke jr select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing conversion  pm nana azurrx biopharma inc azrx ross edmund burke jr owner   indirect view other  pm  azurrx biopharma inc azrx ross edmund burke jr owner   indirect view conversion  pm na azurrx biopharma inc azrx ross edmund burke jr owner   indirect view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  edmund burke jr ross  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors edmund burke jr ross check out list of companies and businesses related to edmund burke jr ross find out edmund burke jr ross address and contact details view other people related to edmund burke jr ross  coworkers colleagues companions etc address co jdj family office services po box  boston  ma companies related to edmund burke jr ross cikcompany namepositioncompany addressazurrx biopharma inc  parkside avenue suite  brooklyn  edmund burke jr ross on the web persons related to edmund burke jr ross  azurrx biopharma incnamepositioncityriddell alastairbrooklynriddell alastairbrooklynmatthew balknew yorkedward borkowski morgantowncharles j casamentounion citycasamento charlesbrooklynrigby christinenew yorkdaniel dupretbrooklynborkowski edwardbrooklynborkowski edwardbrooklynspoor johanbrooklynthijs spoor johannew yorkthijs spoor johanbrooklynthijs spoor johanbrooklynshenouda magedbrooklynshenouda magedbrooklynbalk matthewnew yorkbalk matthewnew yorkpelican partners llc westportalastair riddellbrooklynedmund burke jr ross bostonmaged shenouda new yorkjohan m spoorpresident and ceo boston potentially same personnamecitycountryburke edmunddenvercoburke edmunddallastxburke edmundfort worthtxburke edmunddallastxburke edmunddallastxburke edmunddallastxburke edmunddallastx edmund burke ross born july   american investment executive  prabook create biography you can add biographies of your relatives friends people you admire as well as your own biography log in once logged in you can add biography in the database directories newly added edit profile general education career works life stance personality connections references people also searched for richard j sullivan james edward moore robert hale ives goddard edmund burke ross investment executive edmund burke ross american investment executive trustee peck school morristown new jersey since  member of somerset hills country essex hunt racquet and tennis edgartown yacht background ross edmund burke was born on july   in new york city son of edmund b and margaret haskell ross education bachelor princeton university  master of business administration university chicago  career various to vice president chemical bank new york city  various to executive vice president wesray corporation morristown new jersey since  board directors six flags corporation outlet communications atlas van lines j m petroleum clajon gas company radiokeithorpheum pictures inc politics party affiliation republican religion denomination episcopalian membership trustee peck school morristown new jersey since  member of somerset hills country essex hunt racquet and tennis edgartown yacht personality interests golf tennis ice hockey connections married andrea courchene august   children allyson haskell dana tilford edmund b iii charlotte hamor father edmund b ross mother margaret haskell ross spouse andrea courchene edmund burke ross back to view page see more add photo see on larger map born july   age  new york city nationality american go up edit profile ross edmund burke jr  current holdings  fintelio ross edmund burke jr current holdings from f d investorross edmund burke jr current positions ross edmund burke jr has disclosed  total holdings in their latest sec filings this investor has not filed a f which indicates it has under m in assets under management aum this investor has filed  activist d filings recently which suggests it takes an active role in influencing management ross edmund burke jrs top industries are  overview sec filings dg predictive value all ross edmund burke jr holdings are listed in the following table this data is sourced from dg and f filings green rows indicate new positions red rows indicate closed positions add this fundto your dashboard this is a list of d and g filings made since the last quarterly f report if any file dateformsecurity prevshares currentshares changepercent prev valuex current valuex changepercent ‑‑ sc d azrx  azurrx biopharma inc   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now from the blog how to launch a hedge fund the piotroski score ross edmund burke jr opens position in azrx  azurrx biopharma inc  fintelio ross edmund burke jr opens position in azrx  azurrx biopharma inc securityazrx  azurrx biopharma inc institutionross edmund burke jr shares ownership  june    ross edmund burke jr has filed a sc d form disclosing ownership of  shares of azurrx biopharma inc nasdaqazrx corresponding to an  ownership percentage ross edmund burkemore info this page azrx  azurrx biopharma incmore info ross edmund burke jr ownership holdings in azurrx biopharma inc nasdaqazrx are shown in the following table dont miss an event create an alert dg filings this table shows a history of the dg filings made by the investor andor investor group note that the share values in this table are not directly comparable to any numbers shown in the f table if any filedateeffectivedateform prevshares reportedshares change in sharespercent ownershippercent change in ownershippercent   sc d   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now cusip l iex realtime price become a power user join our private investing channel request membership azurrx biopharm nasdaqazrx stock price news  analysis azurrx biopharm company profile nasdaqazrx company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about azurrx biopharm nasdaqazrx azurrx biopharma inc is a clinical developmentstage biopharmaceutical company the company is engaged in the research and development of nonsystemic biologics for the treatment of patients with gastrointestinal gi disorders the companys product pipeline consists of two therapeutic proteins such as ms and azx ms is an acidresistant secreted lipase produced by yarrowia lipolytica known as lip that the company is developing through recombinant deoxyribonucleic acid dna technology for the treatment of exocrine pancreatic insufficiency epi associated with chronic pancreatitis cp and cystic fibrosis cf azx is a recombinantlactamase combination of bacterial origin under development for the prevention of hospitalacquired infections by resistant bacterial strains induced by parenteral administration of blactam antibiotics known as nosocomial infections as well as the prevention of antibioticassociated diarrhea aad industry sector and symbol sector medical industry na subindustry na symbol nasdaqazrx cusip na web wwwazurrxcom capitalizationmarket cap  millionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio naforeward pe ratio pe growth sales  book valueannual revenue naprice  sales nabook value  per shareprice  book  profitabilityebidta debtcurrent ratio quick ratio miscaverage volume  shsshort ratio    frequently asked questions for azurrx biopharm nasdaqazrx what is azurrx biopharms stock symbol azurrx biopharm trades on the nasdaq under the ticker symbol azrx where is azurrx biopharms stock going where will azurrx biopharms stock price be in   analysts have issued  month price objectives for azurrx biopharms stock their predictions range from  to  on average they anticipate azurrx biopharms share price to reach  in the next twelve months view analyst ratings for azurrx biopharm who are some of azurrx biopharms key competitors some companies that are related to azurrx biopharm include iradimed corporation irmd applied genetic technologies corporation agtc biolinerx blrx gtx gtxi cytrx corporation cytr neovasc nvcn brainstorm cell therapeutics bcli protalix biotherapeutics plx vermillion vrml arqule arql proteostasis therapeutics pti aralez pharmaceuticals arlz dicerna pharmaceuticals drna digirad corporation drad t biosystems ttoo atyr pharma life nexvet biopharma plc nvet and pronai therapeutics srra when did azurrx biopharm ipo azrx raised  million in an initial public offering on friday september th  the company issued  shares at  per share wallachbeth capital and network  financial securities acted as the underwriters for the ipo who owns azurrx biopharm stock azurrx biopharms stock is owned by a variety of of institutional and retail investors top institutional shareholders include ross edmund burke jr  view institutional ownership trends for azurrx biopharm how do i buy azurrx biopharm stock shares of azurrx biopharm can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is azurrx biopharms stock price today one share of azurrx biopharm stock can currently be purchased for approximately  marketbeat community rating for azurrx biopharm nasdaq azrxcommunity ranking   out of    outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about azurrx biopharm and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for azurrx biopharm nasdaqazrx how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for azurrx biopharm nasdaqazrx show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailshc wainwrightinitiated coveragebuy  buyhighwallachbeth capitalinitiated coveragebuynadata available from  forward earnings earnings history for azurrx biopharm nasdaqazrxno earnings announcements for this company have been tracked by marketbeatcom estimates earnings estimates for azurrx biopharm nasdaqazrxcurrent year eps consensus estimate  epsnext year eps consensus estimate  eps dividends dividend history for azurrx biopharm nasdaqazrxno dividend announcements for this company have been tracked by marketbeatcom insider trades insider trading and institutional ownership history for azurrx biopharm nasdaqazrxinstitutional ownership percentage insider trades by quarter for azurrx biopharm nasdaqazrxtransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailspelican partners llcmajor shareholdersell  data available from  forward headlines headline trends for azurrx biopharm nasdaqazrx latest headlines for azurrx biopharm nasdaqazrx source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlinehc wainwright initiates coverage on azurrx biopharm nasdaqazrxwwwamericanbankingnewscom  july  at  ampelican partners llc sells  shares of azurrx biopharm nasdaqazrx stockwwwamericanbankingnewscom  july  at  pmazurrx biopharma announces closing of  million private financingfinanceyahoocom  june  at  pmazurrx biopharma to present at the  ld micro invitational conference june  and the  marcum microcap conference june financeyahoocom  june  at  pmazrx ms  trial first look positive  resultsfinanceyahoocom  april  at  pmazurrx provides update on ms phase ii trialfinanceyahoocom  april  at  pmazurrx biopharma incs lockup period to end on april th nasdaqazrxwwwamericanbankingnewscom  april  at  amazurrx biopharma azrx appoints charles j casamento to board of directorswwwstreetinsidercom  march  at  pmazurrx announces addition of charles j casamento to the board of directorsfinanceyahoocom  march  at  pmlifesci capital initiates coverage of azurrx biopharmafinanceyahoocom  march  at  pmazurrx biopharmas nonsystemic biologics portfolio appears undervaluedseekingalphacom  february  at  pmazrx nonsystemic focus on the gi marketfinanceyahoocom  january  at  pmis azurrx about to transform the gastrointestinal treatment industryfinanceyahoocom  january  at  pmazurrx biopharma an emerging leader to treat gastrointestinal diseaseseekingalphacom  december  at  pmazurrx biopharma to present at the  biotech showcase conferencefinanceyahoocom  december  at  aman emerging leader to treat gastrointestinal diseasefinanceyahoocom  december  at  pmwallachbeth capital initiates research coverage of azurrx biopharmafinanceyahoocom  december  at  amnew collaborations and licensing activities for biotechpharma industries pick up pace heading into wwwprnewswirecom  december  at  amcoverage initiated on azurrx biopharma by wallachbethusrdyahoocom  december  at  pmazurrx biopharma announces agreement in principle with transchem for mtan inhibition technologyusrdyahoocom  december  at  pm am azurrx biopharma agrees in principle with transchem to license transchems proprietary transition state chemistry technology for mtan inhibitionusrdyahoocom  december  at  pmbiotech sector growth expected upon diminishing concerns over drug pricingwwwprnewswirecom  december  at  pmazurrx biopharma to present at the th annual ld micro main eventfinanceyahoocom  november  at  pmazurrx biopharma and mayolyspindler announce initiation of phase iiwwwnasdaqcom  november  at  pmazurrx biopharma and mayolyspindler announce initiation of phase ii clinical trial of mssd for exocrine pancreatic insufficiency in chronic pancreatitis patientsfinanceyahoocom  november  at  pm am azurrx biopharma in partnership with mayoly spindler initiates a phase ii clinical trial evaluating the safety and efficacy of mssd in patients with exocrine pancreatic insufficiency caused by chronic pancreatitisfinanceyahoocom  november  at  pm social chart azurrx biopharm azrx chart for friday july   this page was last updated on  by marketbeatcom staff stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vz log in for events urbn urbn syna ll hp log in for events alks cvrr cvrr esnd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  ross edmund burke jr d filing  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  insider trading  latest d and g filings  d filing  filing details accession number  form type d filing publication date   filed by ross edmund burke jr company azurrx biopharma inc filing date  sec url d filing ownership summary please notice the below summary table is generated without human intervention and may contain errors please refer to the complete filing displayed below for exact figures name sole voting power shared voting power sole dispositive power shared dispositive power aggregate amount owned power percent of class edmund burke ross jr       ebr ventures       adec private equity investment       ceda investments       filing     united states securities and exchange commission washington dc    schedule d     information to be included in statements filed pursuant to rules db c and d and amendments thereto filed pursuant to rule db   under the securities exchange act of      azurrx biopharma inc name of issuer     common stock title of class of securities     l cusip number     june   date of event which requires filing of this statement   if the filing person has previously filed a statement on schedule g to report the acquisition which is the subject of this schedule d and is filing this schedule because of §§ de df or dg check the following box          the remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page   the information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of section  of the securities exchange act of  “act” or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes              cusip no l g                   names of reporting persons   edmund burke ross jr                   check the appropriate box if a member of a group    a ☐   b ☐                    sec use only                   citizenship or place of organization             usa     number of shares  sole voting power   beneficially  shared voting power     owned by each reporting  sole dispositive power   reporting person with   shared dispositive power                     aggregate amount beneficially owned by each reporting person                                   check if the aggregate amount in row  excludes certain shares      ☐                   percent of class represented by amount in row                                    type of reporting person      in        based on  shares of common stock “common stock” outstanding as of june            cusip no l g                   names of reporting persons   ebr ventures llc                   check the appropriate box if a member of a group    a ☐   b ☐                    sec use only                     citizenship or place of organization             delaware       number of shares  sole voting power  beneficially  shared voting power     owned by each reporting  sole dispositive power  reporting person with   shared dispositive power                    aggregate amount beneficially owned by each reporting person                                 check if the aggregate amount in row  excludes certain shares      ☐                   percent of class represented by amount in row                                 type of reporting person      oo        based on  shares of common stock outstanding as of june                cusip no l g                   names of reporting persons   adec private equity investment llc                     check the appropriate box if a member of a group    a ☐   b ☐                     sec use only                     citizenship or place of organization   delaware     number of shares  sole voting power  beneficially  shared voting power     owned by each reporting  sole dispositive power  reporting person with   shared dispositive power                    aggregate amount beneficially owned by each reporting person                      check if the aggregate amount in row  excludes certain shares      ☐                     percent of class represented by amount in row                            type of reporting person      oo        based on  shares of common stock outstanding as of june                cusip no l g                   names of reporting persons   ceda investments llc                     check the appropriate box if a member of a group    a ☐   b ☐                     sec use only                     citizenship or place of organization   delaware       number of shares  sole voting power  beneficially  shared voting power     owned by each reporting  sole dispositive power  reporting person with   shared dispositive power                      aggregate amount beneficially owned by each reporting person                        check if the aggregate amount in row  excludes certain shares      ☐                     percent of class represented by amount in row                            type of reporting person      oo        based on  shares of common stock outstanding as of june           item  security and issuer   this statement on schedule d relates to shares of common stock  par value per share the “common stock” of azur rx biopharma inc a delaware corporation the “issuer” whose principal executive offices are located at  park side avenue downstate biotechnology incubator suite  brooklyn ny    item  identity and background   af this statement is filed by edmund burke ross jr ebr ventures llc adec private equity investment llc and ceda investments llc with respect to shares of common stock that each of the foregoing may be deemed to have a beneficial ownership each of the foregoing is referred to as a “reporting person” and collectively as the “reporting persons”   the address of the principal business office of ebr ventures llc adec private equity investment llc and ceda investments llc is co jdj family office services po box  boston ma  the business address of edmund burke ross jr is co jdj family office services po box  boston ma    mr ross is the manager of ebr ventures llc adec private equity investment llc and ceda investments llc   during the last five years the reporting person has not been convicted in a criminal proceeding excluding traffic violations or similar misdemeanors during the last five years the reporting person has not been a party to any other civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment decree or final order enjoining future violations of or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws   mr ross is a citizen of the united states of america   item  source and amount of funds or other consideration   the securities reported in this statement were acquired with funds provided form working capital of the reporting persons who directly beneficially own such securities   item  purpose of transaction   the reporting persons purchased the securities reported in this statement for investment purposes the reporting persons do not have any current plans proposals or negotiations that relate to or would result in any of the matters referred to in paragraphs a through j of item  of schedule d the reporting persons review their investments on a continuing basis depending on various factors including without limitation the issuer’s financial position the price levels of the shares of common stock conditions in the securities markets and general economic and industry conditions the reporting persons may in the future take such actions with respect to their investment in the issuer as they deem appropriate including without limitation purchasing additional shares of common stock selling shares of common stock engaging in short selling of or any hedging or similar transaction with respect to the common stock taking any other action with respect to the issuer or any of its securities in any manner permitted by law or changing its intention with respect to any and all matters referred to in paragraphs a through j of item          item  interest in securities of the issuer   a b and c as of june   the reporting persons beneficially owned in the aggregate  shares of common stock constituting approximately  of the outstanding common stock the following table sets forth certain information with respect to shares of common stock directly beneficially owned by the reporting persons listed below   name   number of shares of common stock     percentage of outstanding common stock   edmund burke ross jr       ebr ventures llc       adec private equity investment llc       ceda investments llc            includes warrants to purchase  shares of common stock beneficially owned by mr ross of which warrants to purchase  shares of common stock are owned by ebr ventures llc warrants to purchase  shares of common stock are owned by adec private equity investment llc and warrants to purchase  shares of common stock are owned by ceda investments llc   includes warrants to purchase shares of common stock in amount specified in footnote    mr ross is the manager of ebr ventures llc adec private equity investment llc and ceda investments llc and accordingly may be deemed to be the indirect beneficial owner as that term is defined under rule d under the securities exchange act of  as amended the “exchange act” of the common stock that ebr ventures llc adec private equity investment llc and ceda investments llc own mr ross has the sole power to vote or direct the vote or to dispose of  shares of common stock none of ebr ventures llc adec private equity investment llc and ceda investments have power to vote or direct the vote or to dispose any shares of common stock   beneficial ownership of the common stock shown on the cover pages of and set forth elsewhere in this statement for each of the reporting persons assumes that they have not formed a group for purposes of section d under the exchange act and rule db promulgated thereunder if the several reporting persons were deemed to have formed a group for purposes of section d and rule db the group would be deemed to own beneficially and may be deemed to have shared voting and dispositive power over in the aggregate  shares of common stock constituting approximately  of the outstanding shares of common stock   the filing of this schedule d and any future amendment by the reporting persons and the inclusion of information herein and therein with respect to mr ross ebr ventures llc adec private equity investment llc and ceda investments llc shall not be considered an admission that any of such persons for the purpose of section b of the exchange act are the beneficial owners of any shares in which such persons do not have a pecuniary interest mr ross holds sole voting and dispositive power over the shares of common stock and each of adec private equity investment llc ebr ventures llc and ceda investments llc disclaims beneficial ownership of such securities and securities underlying the warrants except to the extent of their respective pecuniary interest therein if any and this report shall not be deemed to be an admission that any of adec private equity investment llc ebr ventures llc or ceda investments llc is the beneficial owner of such securities for the purposes of section  of the securities exchange act of  as amended or for any other purpose   the percentage of shares of common stock reported as being beneficially owned by the based on  shares of common stock outstanding as of june   the reporting persons have not acquired or sold shares of common stock during the last  days   d and e not applicable   item  contracts arrangements understandings or relationships with respect to securities of the issuer   not applicable   item material to be filed as exhibits   not applicable         signature   after reasonable inquiry and to the best of my knowledge and belief i certify that the information set forth in this statement is true complete and correct   dated june     edmund burke ross jr     by s edmund burke ross jr for himself as manager of adec private equity investment llc as manager of ebr ventures llc and as manager of ceda investments llc   name edmund burke ross jr   title manager             hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds hot topics apple aapl latest stock news  company profile warren buffett news  analysis  portfolio  stock picks biggest insider purchases  sales news  analysis  data screener google goog latest stock news  company profile microsoft msft latest stock news  company profile home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved form sc d azurrx biopharma inc filed by ross edmund burke jr research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form sc d azurrx biopharma inc filed by ross edmund burke jr by k wizard—  pm et  httparchivefastedgarcomapaerczajzptzzbahqzsz filed on june   more azrx news azurrx biopharma announces closing of  million private financing globenewswire   am et  azurrx biopharma to present at the  ld micro invitational conference june  and the  marcum microcap conference june  globenewswire   pm et  azurrx provides update on ms phase ii trial globenewswire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  azrx stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsazrx azurrx biopharma inc    as of am et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade price history download to csv file download to excel file log in for more news expand all collapse all briefazurrx biopharma inc files for offering of  million shares of common stock reuters –  am et  azurrx biopharma inc azrx  azurrx biopharma inc azrx files for offering of  million shares of common stock by the selling stockholders source text further company coverage azurrx biopharma announces closing of  million private financing globenewswire –  am et  azurrx biopharma inc azrx a company specializing in the development of nonsystemic recombinant therapies for gastrointestinal diseases announced today the closing of a private placement financing resulting in gross proceeds of  million azurrx biopharma to present at the  ld micro invitational conference june  and the  marcum microcap conference june  globenewswire –  pm et  azurrx biopharma inc azrx a company specializing in the development of nonsystemic recombinant therapies for gastrointestinal diseases announced today the company will be making a company presentation at two upcoming investor conferences the ld micro invitational conference in los angeles  at the luxe sunset boulevard hotel on tuesday june th at  pm pst and at the  marcum microca azurrx provides update on ms phase ii trial globenewswire –  am et  initial patient experience shows no safety issues ms appears active as demonstrated by cfa increases  at various dosing levels azurrx biopharma inc azrx a company specializing in the development of nonsystemic recombinant therapies for gastrointestinal diseases today is providing an update on the ongoing openlabel phase iia trial of lead candidate ms for the treatment of exocrine azurrx announces addition of charles j casamento to the board of directors globenewswire –  am et  azurrx biopharma inc azrx a company specializing in the development of nonsystemic recombinant  therapies for  gastrointestinal diseases today announced the appointment of charles j chuck casamento to the board of directors effective march   since  mr casamento has been executive director and principal of the sage group a health care advisory group page page  todays and upcoming events no events in the next  days past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe